vTv Therapeutics VTVT
NASDAQ VTVT
$30.57 -1.28 (-4.02%)
At close: Oct 2, 2026 · 4:00 PM EDT

vTv Therapeutics (VTVT) Interest & Investment Income (2016 - 2026)

Updated

vTv Therapeutics' Interest & Investment Income was $812,000 in Q2 2026, up 195.3% from $275,000 a year earlier but down 3.1% from the prior quarter.

Analysis

vTv Therapeutics (VTVT) Interest & Investment Income (2016 - 2026) Analysis & Trends

On a trailing twelve-month basis, vTv Therapeutics' Interest & Investment Income was $2.91 million through Jun 30, 2026, up 89.3% year-over-year; for FY2025, it came in at $1.87 million, up 19.5% from FY2024.

  • Interest & Investment Income has now increased for three consecutive years, with a five-year compound annual growth rate of 174.5% (FY2020 to FY2025).
  • In earlier years, Interest & Investment Income was $1.57 million in FY2024 (+231.6%), $472,000 in FY2023 (+34.1%), $352,000 in FY2022 and $1,000 in FY2021 (-91.7%).
  • Quarterly Interest & Investment Income has moved between $50,000 (Q2 2022) and $865,000 (Q4 2025) over five years.
  • Compared with a year earlier, Interest & Investment Income has increased for three straight quarters, with growth averaging 171.3% over the last eight quarters.
  • The best year-over-year quarter for Interest & Investment Income over five years was Q4 2024 (growth of 387.5%); the worst was Q2 2025 (a decline of 50.3%).
  • Per Business Quant data, VTVT's Interest & Investment Income in the three quarters before Q2 2026 was $838,000 (Q1 2026), $865,000 (Q4 2025) and $399,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 vTv Therapeutics 379.35 Mn 379.35 Mn - 812,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 812,000.00
Mar 31, 2026 838,000.00
Dec 31, 2025 865,000.00
Sep 30, 2025 399,000.00
Jun 30, 2025 275,000.00
Mar 31, 2025 331,000.00
Dec 31, 2024 429,000.00
Sep 30, 2024 504,000.00
Jun 30, 2024 553,000.00
Mar 31, 2024 79,000.00
Dec 31, 2023 88,000.00
Sep 30, 2023 131,000.00
Jun 30, 2023 153,000.00
Mar 31, 2023 100,000.00
Dec 31, 2022 152,000.00
Sep 30, 2022 150,000.00
Jun 30, 2022 50,000.00
Mar 31, 2021 1,000.00
Mar 31, 2020 12,000.00
Dec 31, 2019 12,000.00
API Access

vTv Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=VTVT&period=max&api_key=YOUR_API_KEY